By the Numbers
Up-in-coupon continues to lead the way for MBS returns
This document is intended for institutional investors and is not subject to all of the independence and disclosure standards applicable to debt research reports prepared for retail investors. This material does not constitute research.
Conventional 30-year MBS have outperformed hedges over the last three months, according to the Bloomberg Barclays MBS Index. Excess returns started improving in August with coupons 4.0% and higher leading the way. The outperformance subsequently spread to 3.0%s and 3.5%s. Ginnie Mae MBS have also generated positive excess returns across the coupon stack since August. But Ginnies have not favored higher coupons to the same degree as conventionals. Investors may be anticipating that Fed tapering will have a larger effect on conventional MBS than it will on Ginnie Mae MBS.
Conventional and Ginnie Mae 2.5%s have generally performed in-line with hedges for the last few months (Exhibit 1). The graphs plot cumulative excess returns starting from July 1. However conventional 2.0%s have generally underperformed hedges. This was true of Ginnie Mae 2.0%s until August, after which performance began to improve. And Ginnie 2.0%s returns jumped markedly in late September. Meanwhile conventional 3.0%s and 3.5%s have performed much better than Ginnie Mae MBS, although even the Ginnies have generated positive excess returns over the last month. Of course, these returns do not reflect gains from persistently special dollar rolls in lower coupons.
Exhibit 1. Conventional MBS excess returns have favored higher coupons
Excess returns reported by the Bloomberg Barclays MBS index. Excess returns are cumulative starting July 1.
Source: Bloomberg, Amherst Pierpont Securities
Option-adjusted spreads show a similar story. Conventional and Ginnie Mae OASs have been nearly identical in the 2.5% coupon. But Ginnie 2.0% OASs have tightened more than conventional OASs over the last few months. Ginnie 3.5% OASs were roughly the same as conventional OASs at the start of July but are now roughly 15 bp wider. And Ginnie 3.0% OASs have widened relative to conventionals’ since the beginning of October.
Exhibit 2. Conventional and Ginnie Mae MBS OASs
OASs from Bloomberg’s BAM prepayment model.
Source: Bloomberg, Amherst Pierpont Securities
Conventional investors are likely moving up-in-coupon in preparation for Fed tapering. The Fed is only buying 2.0% and 2.5% 30-year MBS, so those are most likely to weaken when tapering starts. But the shift up-in-coupon has not been as strong in Ginnie Mae MBS. This could be due to net supply, which has been extremely high in conventional MBS but very low in Ginnie Mae MBS. And some investors have fewer investment alternatives to Ginnie Mae MBS, which are backed by the full faith and credit of the US government and carry a 0% risk-weighting for banks.
The recent outperformance has pushed MBS returns positive for the year in coupons 3.0% and higher, although the aggregate index return remains negative due to the heavy weight towards lower coupons (Exhibit 3). And these returns do not reflect dollar rolls, which have traded special in 2.5% and lower coupons. That adds substantially to performance for portfolios that can roll their TBA positions. Excess returns on Ginnie Mae MBS are still negative for the year, despite the recent improvement (Exhibit 4).
Exhibit 3. Conventional MBS excess returns (%)
Excess returns reported by the Bloomberg Barclays MBS index.
Source: Bloomberg, Amherst Pierpont Securities
Exhibit 4. Ginnie Mae MBS excess returns (%)
Excess returns reported by the Bloomberg Barclays MBS index.
Source: Bloomberg, Amherst Pierpont Securities
This material is intended only for institutional investors and does not carry all of the independence and disclosure standards of retail debt research reports. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This message, including any attachments or links contained herein, is subject to important disclaimers, conditions, and disclosures regarding Electronic Communications, which you can find at https://portfolio-strategy.apsec.com/sancap-disclaimers-and-disclosures.
Important Disclaimers
Copyright © 2024 Santander US Capital Markets LLC and its affiliates (“SCM”). All rights reserved. SCM is a member of FINRA and SIPC. This material is intended for limited distribution to institutions only and is not publicly available. Any unauthorized use or disclosure is prohibited.
In making this material available, SCM (i) is not providing any advice to the recipient, including, without limitation, any advice as to investment, legal, accounting, tax and financial matters, (ii) is not acting as an advisor or fiduciary in respect of the recipient, (iii) is not making any predictions or projections and (iv) intends that any recipient to which SCM has provided this material is an “institutional investor” (as defined under applicable law and regulation, including FINRA Rule 4512 and that this material will not be disseminated, in whole or part, to any third party by the recipient.
The author of this material is an economist, desk strategist or trader. In the preparation of this material, the author may have consulted or otherwise discussed the matters referenced herein with one or more of SCM’s trading desks, any of which may have accumulated or otherwise taken a position, long or short, in any of the financial instruments discussed in or related to this material. Further, SCM or any of its affiliates may act as a market maker or principal dealer and may have proprietary interests that differ or conflict with the recipient hereof, in connection with any financial instrument discussed in or related to this material.
This material (i) has been prepared for information purposes only and does not constitute a solicitation or an offer to buy or sell any securities, related investments or other financial instruments, (ii) is neither research, a “research report” as commonly understood under the securities laws and regulations promulgated thereunder nor the product of a research department, (iii) or parts thereof may have been obtained from various sources, the reliability of which has not been verified and cannot be guaranteed by SCM, (iv) should not be reproduced or disclosed to any other person, without SCM’s prior consent and (v) is not intended for distribution in any jurisdiction in which its distribution would be prohibited.
In connection with this material, SCM (i) makes no representation or warranties as to the appropriateness or reliance for use in any transaction or as to the permissibility or legality of any financial instrument in any jurisdiction, (ii) believes the information in this material to be reliable, has not independently verified such information and makes no representation, express or implied, with regard to the accuracy or completeness of such information, (iii) accepts no responsibility or liability as to any reliance placed, or investment decision made, on the basis of such information by the recipient and (iv) does not undertake, and disclaims any duty to undertake, to update or to revise the information contained in this material.
Unless otherwise stated, the views, opinions, forecasts, valuations, or estimates contained in this material are those solely of the author, as of the date of publication of this material, and are subject to change without notice. The recipient of this material should make an independent evaluation of this information and make such other investigations as the recipient considers necessary (including obtaining independent financial advice), before transacting in any financial market or instrument discussed in or related to this material.
Important disclaimers for clients in the EU and UK
This publication has been prepared by Trading Desk Strategists within the Sales and Trading functions of Santander US Capital Markets LLC (“SanCap”), the US registered broker-dealer of Santander Corporate & Investment Banking. This communication is distributed in the EEA by Banco Santander S.A., a credit institution registered in Spain and authorised and regulated by the Bank of Spain and the CNMV. Any EEA recipient of this communication that would like to affect any transaction in any security or issuer discussed herein should do so with Banco Santander S.A. or any of its affiliates (together “Santander”). This communication has been distributed in the UK by Banco Santander, S.A.’s London branch, authorised by the Bank of Spain and subject to regulatory oversight on certain matters by the Financial Conduct Authority (FCA) and the Prudential Regulation Authority (PRA).
The publication is intended for exclusive use for Professional Clients and Eligible Counterparties as defined by MiFID II and is not intended for use by retail customers or for any persons or entities in any jurisdictions or country where such distribution or use would be contrary to local law or regulation.
This material is not a product of Santander´s Research Team and does not constitute independent investment research. This is a marketing communication and may contain ¨investment recommendations¨ as defined by the Market Abuse Regulation 596/2014 ("MAR"). This publication has not been prepared in accordance with legal requirements designed to promote the independence of research and is not subject to any prohibition on dealing ahead of the dissemination of investment research. The author, date and time of the production of this publication are as indicated herein.
This publication does not constitute investment advice and may not be relied upon to form an investment decision, nor should it be construed as any offer to sell or issue or invitation to purchase, acquire or subscribe for any instruments referred herein. The publication has been prepared in good faith and based on information Santander considers reliable as of the date of publication, but Santander does not guarantee or represent, express or implied, that such information is accurate or complete. All estimates, forecasts and opinions are current as at the date of this publication and are subject to change without notice. Unless otherwise indicated, Santander does not intend to update this publication. The views and commentary in this publication may not be objective or independent of the interests of the Trading and Sales functions of Santander, who may be active participants in the markets, investments or strategies referred to herein and/or may receive compensation from investment banking and non-investment banking services from entities mentioned herein. Santander may trade as principal, make a market or hold positions in instruments (or related derivatives) and/or hold financial interest in entities discussed herein. Santander may provide market commentary or trading strategies to other clients or engage in transactions which may differ from views expressed herein. Santander may have acted upon the contents of this publication prior to you having received it.
This publication is intended for the exclusive use of the recipient and must not be reproduced, redistributed or transmitted, in whole or in part, without Santander’s consent. The recipient agrees to keep confidential at all times information contained herein.
